Article | July 28, 2021

Assembling A New Gene Therapy Company To Develop The Next Generation Of Pioneering Medicines

By Christina Maat, Junior Technician at VectorY and Charlotte McLure, Junior Technician at VectorY

DNA Cell and Gene puzzle iStock-1176815811

Despite the difficulties associated with start-ups and hurdles presented by the pandemic, Advance Biotech Grant Winner VectorY, an Amsterdam based gene therapy company, continues to make steps towards developing vectorized antibodies to treat diseases of high unmet medical need with a specific focus on muscle and neuromuscular disease. Continue reading to learn what makes VecorY stand out from the rest.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: